CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool

被引:123
作者
Brokowski, Carolyn [1 ]
Adli, Mazhar [2 ]
机构
[1] Yale Sch Med, Dept Emergency Med, 464 Congress Ave, New Haven, CT 06519 USA
[2] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA
基金
美国国家卫生研究院;
关键词
CRISPR-Cas9; research ethics; genome editing; genetic engineering; bioengineering; ONE-STEP GENERATION; GENE DRIVE SYSTEM; TARGETED MUTAGENESIS; CELL ORGANOIDS; GENOMIC DNA; CAS9; RNA; MALARIA; MUTATIONS; GUIDE;
D O I
10.1016/j.jmb.2018.05.044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the emergence of CRISPR technology, targeted editing of a wide variety of genomes is no longer an abstract hypothetical, but occurs regularly. As application areas of CRISPR are exceeding beyond research and biomedical therapies, new and existing ethical concerns abound throughout the global community about the appropriate scope of the systems' use. Here we review fundamental ethical issues including the following: 1) the extent to which CRISPR use should be permitted; 2) access to CRISPR applications; 3) whether a regulatory framework(s) for clinical research involving human subjects might accommodate all types of human genome editing, including editing of the germline; and 4) whether international regulations governing inappropriate CRISPR utilization should be crafted and publicized. We conclude that moral decision making should evolve as the science of genomic engineering advances and hold that it would be reasonable for national and supranational legislatures to consider evidence-based regulation of certain CRISPR applications for the betterment of human health and progress. (C) 2018 Published by Elsevier Ltd.
引用
收藏
页码:88 / 101
页数:14
相关论文
共 153 条
[1]   RNA targeting with CRISPR-Cas13 [J].
Abudayyeh, Omar O. ;
Gootenberg, Jonathan S. ;
Essletzbichler, Patrick ;
Han, Shuo ;
Joung, Julia ;
Belanto, Joseph J. ;
Verdine, Vanessa ;
Cox, David B. T. ;
Kellner, Max J. ;
Regev, Aviv ;
Lander, Eric S. ;
Voytas, Daniel F. ;
Ting, Alice Y. ;
Zhang, Feng .
NATURE, 2017, 550 (7675) :280-+
[2]   A Critical Assessment of Vector Control for Dengue Prevention [J].
Achee, Nicole L. ;
Gould, Fred ;
Perkins, T. Alex ;
Reiner, Robert C., Jr. ;
Morrison, Amy C. ;
Ritchie, Scott A. ;
Gubler, Duane J. ;
Teyssou, Remy ;
Scott, Thomas W. .
PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (05)
[3]   The CRISPR tool kit for genome editing and beyond [J].
Adli, Mazhar .
NATURE COMMUNICATIONS, 2018, 9
[4]  
Allkin B., 2017, Useful plants-medicines: at least 28,187 plant species are currently recorded as being of medicinal use
[5]   Editing the human genome: balancing safety and regulation [J].
不详 .
LANCET, 2018, 391 (10119) :402-402
[6]  
[Anonymous], Nutrition
[7]  
[Anonymous], Buck v. Bell, Patent No. 2001927
[8]  
[Anonymous], 2018, NAT AC SCI ENG MED N
[9]  
[Anonymous], 2017, HUM EMBR CULT DISC C
[10]  
[Anonymous], Patent No. 3122017